GENOVIS SIGNS DISTRIBUTION AGREEMENT WITH FINNZYMES INC. IN US

Genovis is represented in the US through its subsidiary Genovis Inc. and is now sharing its promotional activity with, and transferring its US-based logistical operations to Finnzymes Inc. as of Febuary 1, 2009.

Genovis offers new technological solutions in Transfection, RNAi, Imaging, and Antibody Engineering to customers who are performing sophisticated research in pharmaceutical companies and within the academic research community.

- We are excited about the opportunity this distribution agreement presents for Genovis. It is a means of broadening our presence within the US marketplace and we are looking forward to working with Finnzymes experienced team, says Sarah Fredriksson, CEO of Genovis.

Finnzymes Inc is a wholly owned subsidiary of Finnzymes Oy and a distributor of Finnzymes products in North America. Finnzymes Oy, located in Finland and founded in 1986, refines scientific innovations into useful commercial products for molecular biologists and is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Their product line includes all components required for PCR: DNA polymerases, PCR instruments and reaction vessels.

-Our mission at Finnzymes Inc. is to offer products which will measurably improve the lab bench experience for researchers throughout the US scientific community. We are therefore extremely pleased to be able to work with Genovis, which has a unique portfolio of products based upon highly advanced technologies, such as their proprietary nanoparticles for ultra-high efficiency transfection, says Mike Mortillaro, President of Finnzymes Inc.